ClinicalTrials.gg
BiologicalDrug

Sotrovimab clinical trials

Also written VIR-7831 and GSK4182136.

studies test it
17
open now
2
in phase 3
7
first study started
2020

How each study uses sotrovimab is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the sotrovimab studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
17 Dec 2021 · Xevudy · EMEA/H/C/005676 (EMA; now withdrawn)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Sotrovimab
12

Development codes

VIR-7831
5
GSK4182136
2

Studies by the year they started

17 studies that test it; most in 2021 (8)

Studies that test sotrovimab, by start year
YearStudies
20205
20218
20224

By phase

A phase 1/2 study counts in both.

Phase 1
3
Phase 2
7
Phase 3
7
Phase 4
2

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 8 · Other 9

Vir Biotechnology, Inc. (5) · GlaxoSmithKline (2) · National Institute of Allergy and Infectious Diseases (NIAID) (2) · University of Oxford (2) · Cambridge University Hospitals NHS Foundation Trust (1) · Sophia Koo, M.D. (1) · Eli Lilly and Company (1) · Fred Hutchinson Cancer Center (1)

Often tested with

Tested in the same studies.

Bamlanivimab (2) · Bebtelovimab (2) · Hydroxychloroquine (2) · Molnupiravir (2) · Nirmatrelvir and ritonavir drug combination (2) · Cilgavimab and tixagevimab drug combination (1) · Ensovibep (1) · Lufotrelvir (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 1

Studies that test sotrovimab.

Studies

Open first, then newest update. How each study uses sotrovimab is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 17

As the comparator · 2 — what is tested is compared with sotrovimab

Codes

What other systems call sotrovimab · ClinicalTrials.gg INT001486

  • MeSH (NLM) C000711967sotrovimabConfirmed ClinicalTrials.gov, NLM
  • UNII (FDA) 1MTK0BPN8VSOTROVIMABConfirmed FDA, NLM, Wikidata
  • RxNorm 2550731One source FDA
  • Wikidata Q106943333SotrovimabConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C177059SotrovimabOne source FDA
  • DrugBank DB16355One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.